Januvia Gains Indication For Initial Diabetes Treatment With Metformin
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling for Merck’s DPP-4 inhibitor is also updated to include additional new regimens, as well as warning on hypersensitivity reactions.
You may also be interested in...
Novo Nordisk’s Liraglutide Set For March 2009 PDUFA
Phase II study of once-weekly GLP-1 analog is under way, with results due next year.
Novo Nordisk’s Liraglutide Set For March 2009 PDUFA
Phase II study of once-weekly GLP-1 analog is under way, with results due next year.
Merck Gets Janumet Label Extended
Combo drug’s new indications follow similar extensions last year for the pair when taken in tandem.